suga yukio 菅幸生

… Alternative Names

SUGA YUKIO 菅幸生

SUGA Yukio 菅幸生

Less

Researcher Number	00467101
Other IDs
Affiliation (Current)	2025: 金沢大学, 薬学系, 教授
Affiliation (based on the past Project Information) *help	2022 – 2023: 金沢大学, 薬学系, 教授 2017 – 2021: 金沢大学, 薬学系, 准教授 2013 – 2016: 金沢大学, 薬学系, 助教 2010 – 2011: 金沢大学, 薬学系, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy / Clinical nursing Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator 臓器障害 / 線溶抑制 / 出血症状 / DIC / TRPA1 / 副作用管理 / がん薬物療法 / オキサリプラチン / 血管痛 / PAI … More / 線溶活性化 / 出血 / 多臓器不全 / 血栓 / 線溶療法 / ROS / 抗酸化剤 / 予防対策 / 投与液pH / 血管痛評価モデル / 単位時間当たりの投与量 / 血管痛の抑制 / ゲムシタビン / 栄養障害 / 栄養状態 / 嗅覚障害 / 癌化学療法 … More Except Principal Investigator 体内動態 / 薬物動態 / トランスポーター / 成長過程 / バルプロ酸 / ミコフェノール酸 / ボリコナゾール / 相互作用 / シクロスポリン / メトトレキサート / 腸肝循環 / 薬物代謝 / 薬物代謝酵素 / 薬物体内動態 / 副作用 / 経皮吸収 / 肥満 / 体内動態変動 / 適正使用 / TDM / 小児 Less

線溶病態に着目したDICにおける多発血栓形成プロセスの解明とその治療応用Principal Investigator
- Principal Investigator
  
  菅幸生
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kanazawa University
Development of new therapeutic strategy and elucidation of fibrinolytic pathophysiology which play a key role in multiple thrombus formation in disseminated intravascular coagulationPrincipal Investigator
- Principal Investigator
  
  Suga Yukio
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kanazawa University
Development of new preventive strategy and elucidation of mechanism for cancer chemotherapy-induced vascular painPrincipal Investigator
- Principal Investigator
  
  SUGA YUKIO
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kanazawa University
Strategy for avoidance of adverse drug reaction caused by obese
- Principal Investigator
  
  SAI Yoshimichi
- Project Period (FY)
  2015 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kanazawa University
Development of prophylactic method and clarification of mechanism for anti-tumor drug-induced vascular pain by using approach both basic and clinical studiesPrincipal Investigator
- Principal Investigator
  
  SUGA YUKIO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kanazawa University
Research of Change in Pharmacokinetics Related with Age and/or Physical Function
- Principal Investigator
  
  ISHIZAKI JUNKO
- Project Period (FY)
  2012 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kanazawa University
Research of olfactory dysfunction induced by antitumor drug and its early detection for maintenance of adequate nutritional status in cancer patientsPrincipal Investigator
- Principal Investigator
  
  SUGA Yukio
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Clinical nursing
- Research Institution
  Kanazawa University
Research of Change in Pharmacokinetics as a Function of Age Intended Optimization of Drug Therapy in children
- Principal Investigator
  
  ISHIZAKI Junko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kanazawa University

All 2021 2020 2019 2016 2015 2012 2011 2010 2009 Other

All Journal Article Presentation

[Journal Article] Potential of continuous tPA infusion for MOF from lipopolysaccharide-induced disseminated intravascular coagulation in rats2021
- Author(s)
  Suga Y, Tashiro K, Staub Y, Komura S, Yamada S, Morishita E, Asakura H
- Journal Title
  
  Thromb Res
  
  Volume: 206 Pages: 84-87
- DOI
  10.1016/j.thromres.2021.08.014
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09430, KAKENHI-PROJECT-20K07151
[Journal Article] Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods2019
- Author(s)
  Suga Y, Ikeda N, Maeda M, Staub AY, Shimada T, Yonezawa M, Kitade H, Katsura H, Okada M, Ishizaki J, Sai Y, Matsushita R
- Journal Title
  
  J. Pharm. Health Care Sci.
  
  Volume: 4 Issue: 1 Pages: 27-27
- DOI
  10.1186/s40780-018-0117-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K08397
[Journal Article] Change in pharmacokinetics of mycophenolic acid as a function of age in rats and effect of coadministered amoxicillin/clavulanate2012
- Author(s)
  Ishizaki, J., Tsuda, T., Suga, Y., Ito, S., Arai, K., Sai, Y., Miyamoto, K.
- Journal Title
  
  Biol. Pharm. Bull.
  
  Volume: (in press)
- NAID
  130001872101
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590154
[Journal Article] ゲムシタビン塩酸塩の経静脈投与による血管通の危険因子の解析とNSAIDs・オピオイドによる予防効果の評価2012
- Author(s)
  菅　幸生
- Journal Title
  
  医療薬学
  
  Volume: 38 Pages: 177-183
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590184
[Journal Article] 小児と成人におけるボリコナゾールの血中濃度解析の比較2010
- Author(s)
  伊藤さつき, 石崎純子, 小柴美紀恵, 五十嵐康郎, 長田直人, 菅幸生, 西村良成, 前馬秀明, 小泉晶一, 中尾眞二, 横川弘一, 崔吉道, 宮本謙一
- Journal Title
  
  医療薬学
  
  Volume: 36 Pages: 213-219
- NAID
  130004502587
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590154
[Presentation] ラットDICモデルを用いた研究のピットフォール-DIC誘発物質の違いによる病態の違い-2021
- Author(s)
  菅　幸生, 朝倉英策
- Organizer
  第15回日本血栓止血学会学術標準化委員会シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-20K07151
[Presentation] LPS誘発DICモデルに対するtPAによる臓器障害の軽減効果2020
- Author(s)
  菅　幸生, スタッブ由紀子, 田代精亨, 朝倉英策
- Organizer
  第21回日本検査血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20K07151
[Presentation] 骨肉腫患者におけるメトトレキサート排泄遅延因子の検討2016
- Author(s)
  三坂　恒、菅　幸生、津幡　あつ美、スタッブ由紀子、嶋田　努、松下　良、崔　吉道
- Organizer
  第27回日本病院薬剤師会北陸ブロック学術大会
- Place of Presentation
  北陸大学（金沢市）
- Year and Date
  2016-11-27
- Data Source
  KAKENHI-PROJECT-15K08092
[Presentation] オキサリプラチンによる血管痛の予防対策の評価および危険因子の解析2015
- Author(s)
  池田菜々，菅　幸生，前田真奈美，岡田守弘，桂　英之，北出鉱規，米澤美和，石﨑純子，嶋田　努，柏原宏暢，崔　吉道，松下　良
- Organizer
  日本医療薬学会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-25860109
[Presentation] バルプロ酸の血漿中濃度と肝機能との関係2012
- Author(s)
  河辺志帆,石崎純子,東夏宵,菅幸生,荒井國三,崔吉道,宮本謙一
- Organizer
  日本薬学会第132年会
- Place of Presentation
  北海道大学(北海道)
- Year and Date
  2012-03-29
- Data Source
  KAKENHI-PROJECT-21590154
[Presentation] 成長過程における抗てんかん薬バルプロ酸の薬物動態の変動2012
- Author(s)
  東夏宵,石崎純子,菅幸生,荒井國三,崔吉道,宮本謙一
- Organizer
  日本薬学会第132年会
- Place of Presentation
  北海道大学(北海道)
- Year and Date
  2012-03-30
- Data Source
  KAKENHI-PROJECT-21590154
[Presentation] 簡易型嗅覚検査キットを用いたがん化学療法施行患者における嗅覚異常の実態調査および栄養状態との関連2011
- Author(s)
  菅幸生
- Organizer
  第21回日本医療薬学会
- Place of Presentation
  神戸国際展示場(兵庫県)
- Year and Date
  2011-10-02
- Data Source
  KAKENHI-PROJECT-22792176
[Presentation] 簡易型嗅覚検査キットを用いたがん化学療法施行患者における嗅覚異常の実態調査および栄養状態との関連2011
- Author(s)
  菅幸生
- Organizer
  日本医療薬学会
- Place of Presentation
  神戸国際展示場(兵庫県)
- Year and Date
  2011-10-02
- Data Source
  KAKENHI-PROJECT-22792176
[Presentation] がん化学療法による嗅覚機能障害の実態調査2010
- Author(s)
  菅幸生
- Organizer
  第20回日本医療薬学会
- Place of Presentation
  幕張メッセ(千葉県)
- Year and Date
  2010-11-13
- Data Source
  KAKENHI-PROJECT-22792176
[Presentation] がん化学療法による嗅覚機能障害の実態調査2010
- Author(s)
  菅幸生
- Organizer
  医療薬学会
- Place of Presentation
  幕張メッセ(千葉県)
- Year and Date
  2010-11-13
- Data Source
  KAKENHI-PROJECT-22792176
[Presentation] 成長過程における免疫抑制剤ミコフェノール酸の体内動態変動2010
- Author(s)
  石崎純子,津田智子,菅幸生,荒井國三,崔吉道,宮本謙一
- Organizer
  第20回日本医療薬学会年会
- Place of Presentation
  幕張メッセ国際展示場(千葉県)
- Year and Date
  2010-11-13
- Data Source
  KAKENHI-PROJECT-21590154
[Presentation] 小児における免疫抑制剤ミコフェノール酸の体内動態2009
- Author(s)
  津田智子,石崎純子,小柴美紀恵,長田直人,菅幸生,荒井國三,西村良成,谷内江昭宏,崔吉道,宮本謙一
- Organizer
  第19回日本医療薬学会年会
- Place of Presentation
  長崎県立総合体育館(長崎県)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-21590154
[Presentation] 生理的条件以下の投与液浸透圧とオキサリプラチンによる血管痛の関連
- Author(s)
  菅幸生，他6名
- Organizer
  日本臨床腫瘍学会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-25860109
[Presentation] オキサリプラチン溶液の浸透圧が血管痛におよぼす影響
- Author(s)
  前田真奈美，菅幸生，他
- Organizer
  日本医療薬学会
- Place of Presentation
  名古屋
- Year and Date
  2014-09-27 – 2014-09-28
- Data Source
  KAKENHI-PROJECT-25860109

1. ISHIZAKI Junko (60401890)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
2. SAI Yoshimichi (40262589)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. 嶋田努 (90409384)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
4. MIYAMOTO Ken-ichi (30100514)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
5. AKASHITA Gaku

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 隹吉道

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 朝倉英策

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

suga yukio 菅 幸生

SUGA YUKIO 菅 幸生

SUGA Yukio 菅 幸生

Research Projects

Research Products

Co-Researchers

線溶病態に着目したDICにおける多発血栓形成プロセスの解明とその治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new therapeutic strategy and elucidation of fibrinolytic pathophysiology which play a key role in multiple thrombus formation in disseminated intravascular coagulationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new preventive strategy and elucidation of mechanism for cancer chemotherapy-induced vascular painPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Strategy for avoidance of adverse drug reaction caused by obese

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of prophylactic method and clarification of mechanism for anti-tumor drug-induced vascular pain by using approach both basic and clinical studiesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research of Change in Pharmacokinetics Related with Age and/or Physical Function

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research of olfactory dysfunction induced by antitumor drug and its early detection for maintenance of adequate nutritional status in cancer patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research of Change in Pharmacokinetics as a Function of Age Intended Optimization of Drug Therapy in children

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Potential of continuous tPA infusion for MOF from lipopolysaccharide-induced disseminated intravascular coagulation in rats2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Change in pharmacokinetics of mycophenolic acid as a function of age in rats and effect of coadministered amoxicillin/clavulanate2012

Author(s)

Journal Title

NAID

Data Source

[Journal Article] ゲムシタビン塩酸塩の経静脈投与による血管通の危険因子の解析とNSAIDs・オピオイドによる予防効果の評価2012

Author(s)

Journal Title

Data Source

[Journal Article] 小児と成人におけるボリコナゾールの血中濃度解析の比較2010

Author(s)

Journal Title

NAID

Data Source

[Presentation] ラットDICモデルを用いた研究のピットフォール-DIC誘発物質の違いによる病態の違い-2021

Author(s)

suga yukio 菅幸生

SUGA YUKIO 菅幸生

SUGA Yukio 菅幸生